Comments
SMS Pharmaceuticals has received approval from the US health regulator for its Andhra Pradesh based manufacturing facility.
The company has received approval from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, SMS Pharmaceuticals said in a regulatory filing.
The USFDA had conducted inspection of the plant in the third week of April this year, it added.
SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.
The company’s shares today closed at Rs 123, down by 1.01 per cent on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.